234 related articles for article (PubMed ID: 10413853)
1. [Blood coagulation and fibrinolysis in arteriosclerosis].
Hoffmeister HM; Heller W; Seipel L
Z Kardiol; 1999 May; 88(5):315-23. PubMed ID: 10413853
[TBL] [Abstract][Full Text] [Related]
2. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
3. Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.
Hoffmeister HM; Jur M; Wendel HP; Heller W; Seipel L
Circulation; 1995 May; 91(10):2520-7. PubMed ID: 7743613
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology of acute coronary syndromes].
Ogawa H
J Cardiol; 1999 Mar; 33 Suppl 1():9-16. PubMed ID: 10342131
[TBL] [Abstract][Full Text] [Related]
5. [Role of the hemostasis in unstable angina pectoris].
Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
Pol Merkur Lekarski; 2004 May; 16(95):468-71. PubMed ID: 15518429
[TBL] [Abstract][Full Text] [Related]
6. Correlation between coronary morphology and molecular markers of fibrinolysis in unstable angina pectoris.
Hoffmeister HM; Jur M; Helber U; Fischer M; Heller W; Seipel L
Atherosclerosis; 1999 May; 144(1):151-7. PubMed ID: 10381288
[TBL] [Abstract][Full Text] [Related]
7. [Atherothrombosis and inflammation].
Hoffmeister HM
Z Kardiol; 2001 Jun; 90(6):379-84. PubMed ID: 11486571
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis and fibrinolysis in acute myocardial infarction.
Eisenberg PR
Alcohol Clin Exp Res; 1994 Feb; 18(1):97-104. PubMed ID: 8198233
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator release and plasminogen activator inhibitor levels in coronary artery disease.
Meyers DG; Haire WD; Rasmussen JK; Boyd EJ
Angiology; 1991 Jul; 42(7):561-7. PubMed ID: 1907440
[TBL] [Abstract][Full Text] [Related]
11. [Markers for the prognosis of success of coronary interventions: focus on changes in fibrinolysis and hemostasis].
Hoffmeister HM
Herz; 2001 Apr; 26 Suppl 1():19-23. PubMed ID: 11349621
[TBL] [Abstract][Full Text] [Related]
12. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?
von Känel R; Mills PJ; Fainman C; Dimsdale JE
Psychosom Med; 2001; 63(4):531-44. PubMed ID: 11485106
[TBL] [Abstract][Full Text] [Related]
13. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.
Jax TW; Peters AJ; Plehn G; Schoebel FC
Cardiovasc Diabetol; 2009 Sep; 8():48. PubMed ID: 19735543
[TBL] [Abstract][Full Text] [Related]
15. Relationship of blood coagulation and fibrinolysis to vital exhaustion.
Kop WJ; Hamulyák K; Pernot C; Appels A
Psychosom Med; 1998; 60(3):352-8. PubMed ID: 9625224
[TBL] [Abstract][Full Text] [Related]
16. Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia.
Wu W; Liu R; Chen L; Chen H; Zhang S
Medicine (Baltimore); 2016 Feb; 95(8):e2779. PubMed ID: 26937905
[TBL] [Abstract][Full Text] [Related]
17. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
Voss R; Matthias FR; Borkowski G; Reitz D
Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
[TBL] [Abstract][Full Text] [Related]
18. [Tissue plasminogen activator, its inhibitor and other factors of the blood fibrinolytic system in stable coronary heart disease].
Zateĭshchikov DA; Averkov OV; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Storozhilova AN
Kardiologiia; 1992 Feb; 32(2):9-12. PubMed ID: 1527946
[TBL] [Abstract][Full Text] [Related]
19. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
20. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
